Camber Pharmaceuticals Launches Generic Marinol®

Piscataway, NJ, February 11, 2020– Camber Pharmaceuticals is pleased to announce the addition of Dronabinol Capsules to our growing portfolio of products.
Dronabinol Capsules is the generic version of Marinol®. Dronbinol is used to nausea and vomiting caused by cancer chemotherapy. Dronabinol is also used to treat loss of appetite and weight loss in people with HIV infection.
Dronabinol Capsules is available in a 2.5, 5, and 10mg- 60ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the
market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection